WaferGen, MPLN Partner on NGS-based Clinical Test Development | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems today announced a partnership with Molecular Pathology Laboratory Network to develop next-generation sequencing-based clinical tests.

According to MPLN VP of Genomic Solutions Jamie Platt, the first product to be commercialized from the deal will be a solid tumor panel to complement the lab's Pathology Partners Program and support MPLN's expanding molecular oncology services menu.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.